Quick Answer
AETHLON MEDICAL INC reported Operating Income Loss of -$9.34 million for the year ending 2025.
- AETHLON MEDICAL INC showed an increase of +26.1% in Operating Income Loss from 2024 to 2025.
- This data is from AETHLON MEDICAL INC's annual report (Form 10-K), filed with the SEC on June 26, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2012: -$936.8 thousand | Q2 2013: -$783.8 thousand | Q3 2013: -$229.8 thousand | Q4 2013: -$1.23 million | Q2 2014: -$1.17 million | Q3 2014: -$601.2 thousand | Q4 2014: -$1.09 million | Q2 2015: -$1.09 million | Q3 2015: -$1.12 million | Q4 2015: -$1.08 million | Q2 2016: -$1.13 million | Q3 2016: -$2.23 million | Q4 2016: -$1.24 million | Q2 2017: -$1.16 million | Q3 2017: -$1.24 million | Q4 2017: -$1.16 million | Q2 2018: -$1.10 million | Q3 2018: -$1.35 million | Q4 2018: -$1.96 million | Q2 2019: -$1.57 million | Q3 2019: -$1.70 million | Q4 2019: -$876.4 thousand | Q2 2020: -$1.41 million | Q3 2020: -$1.77 million | Q4 2020: -$2.44 million | Q2 2021: -$2.10 million | Q3 2021: -$2.01 million | Q4 2021: -$2.53 million | Q2 2022: -$2.91 million | Q3 2022: -$3.67 million | Q4 2022: -$2.85 million | Q2 2023: -$3.41 million | Q3 2023: -$3.18 million | Q4 2023: -$3.57 million | Q2 2024: -$2.62 million | Q3 2024: -$2.90 million | Q4 2024: -$1.81 million | Q2 2025: -$1.79 million | Q3 2025: -$1.51 million | Q4 2025: -$2.06 million.
- Over the full 15 years of available data (2011 to 2025), AETHLON MEDICAL INC's Operating Income Loss has declined by 105.0%.
- Historical annual values: Fiscal year 2025: -$9.34 million | Fiscal year 2024: -$12.64 million | Fiscal year 2023: -$11.90 million | Fiscal year 2022: -$10.42 million | Fiscal year 2021: -$7.89 million | Fiscal year 2020: -$5.93 million | Fiscal year 2019: -$6.00 million | Fiscal year 2018: -$4.83 million | Fiscal year 2017: -$6.10 million | Fiscal year 2016: -$4.38 million | Fiscal year 2015: -$3.99 million | Fiscal year 2014: -$3.06 million | Fiscal year 2013: -$3.58 million | Fiscal year 2012: -$3.11 million | Fiscal year 2011: -$4.56 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: